GovChime
UEI: XVW6MZUM8NH3 • CAGE: 94ZE6

Oxford Immunotec USA, Inc (MA)

DBA: OXFORD IMMUNOTEC

Registration and award facts

SAM.gov registration as of

Net obligations since FY2022
$364.16K
$364,163under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
3
with positive net obligations1 IDV vehicle held
Latest action
Sep 27, 2024
SAM.gov registration
Inactive
Registration expiration date Mar 19, 2024

Registration

Doing business as
OXFORD IMMUNOTEC
Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Sep 28, 2018 (8 years)
Location
Marlborough, MA
State of incorporation
Delaware
Purpose of registration
All Awards

† FY2026 obligations (provisional; DoD awards signed after Jul 29, 2026 are not yet public).

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI XVW6MZUM8NH3. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2022. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2024: $46,641
  • FY2023: $87,490
  • FY2022: $230,033

Total across 3 fiscal years: $364,163

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • 6550In vitro diagnostic substances, reagents, test kits and sets$364,163, 100%

Capabilities

NAICS codes

Small: small business for that NAICS, self-certified in SAM.gov registration.

SBA certifications

No certification in the SBA profile data.

Federal Capability Statement

Oxford Immunotec is a global, high-growth diagnostics company. We bring energy and invention to a world in need of diagnostic truth. We are uniquely placed as the only company in the world offering regulated ELISPOT assays for T cell measurement, with approval around the globe. Our leading product, the T-SPOT®.TB test, is used for diagnosing infection with Tuberculosis, the world’s largest cause of death from infectious disease. The Company has over 18 years’ experience as a manufacturer of IVD tests, operating under a fully audited Quality Management System, ensuring rigorous batch control. The company has manufactured in excess of 20 million clinical T cell tests for TB infection. The T-SPOT.TB test has been approved for sale in over 50 countries, including the United States (where it has received pre-market approval from the Food and Drug Administration), Europe (where it has obtained a CE mark), as well as Japan and China.

Capabilities & Services

diagnostics
infectious disease
assays

Contracts

Latest awards and orders

  1. 36C24222A0001Blanket purchase agreement (BPA)VehicleDepartment of Veterans AffairsLatest action
  2. 36C24223N0099BPA callunder a blanket purchase agreement (BPA)Department of Veterans AffairsLatest action
  3. 36C24224N0083BPA callunder a blanket purchase agreement (BPA)Department of Veterans AffairsLatest action
  4. 36C24222N0046BPA callunder a blanket purchase agreement (BPA)Department of Veterans AffairsLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for Oxford Immunotec USA, Inc lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

293 BOSTON POST RD W STE 210

MARLBOROUGH, MA, 01752

USA

Mailing Address

293 BOSTON POST RD W STE 210

MARLBOROUGH, MA, 01752

USA

Government Business Contact

Jessica Tatem

Marketing Communications Manager

293 Boston Post Road West Suite 210

Marlborough, MA, 01752

USA

Electronic Business Contact

Jessica Tatem

Marketing Communications Manager

293 Boston Post Road West Suite 210

Marlborough, MA, 01752

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

Oxford Immunotec USA, Inc has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires March 19, 2024.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Registered for disaster relief contracting

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Foreign Owned

Registration Details

Source: SAM.gov

Initial Registration

Aug 23, 2021

Last Update

Apr 5, 2025

Registration Activation

Active — Mar 21, 2023

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

03